23 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2251543/aldeyra-aldx-stock-rallies-43-in-one-week-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2251543
Apr 06, 2024 - Aldeyra (ALDX) rises 43% in one week, driven by plans to initiate a pivotal study to support the resubmission of reproxalap NDA for dry eye disease in the first half of 2024.
zc:-6587684223321157219
0
https://www.zacks.com/commentary/2252707/top-stock-reports-for-abbvie-salesforce-general-electric?cid=CS-ZC-FT-research_daily-2252707
Apr 09, 2024 - Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Salesforce, Inc. (CRM) and General Electric Company (GE).
zc:2624957013781475806
0
https://www.zacks.com/stock/news/2253493/are-you-looking-for-a-high-growth-dividend-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2253493
Apr 10, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
zc:-3544081025948954067
0